Compare DexCom, Inc. (DXCM) vs Plug Power Inc (PLUG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Plug Power Inc — how do they compare? DexCom, Inc. trades at $77.49 (market cap $28.06B), while Plug Power Inc trades at $2.15 (market cap $3.08B). The key difference: DexCom, Inc. is far larger — about 9.1× Plug Power Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | PLUG | |
|---|---|---|
Market Cap | $28.06B | $3.08B |
Sector | Health | Industrials |
52-Week High | $89.53 | $4.14 |
52-Week Low | $54.84 | $1.40 |
Enterprise Value | $27.03B | $3.87B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $74.12, down 2.92% on the day, with a bullish technical signal from moving averages. The company demonstrates strong fundamentals with consistent revenue growth, expanding profit margins, and a track record of beating earnings estimates. Recent regulatory approvals for its G7 15-day CGM in Canada and pediatric clearance for its Stelo OTC system in the U.S. highlight ongoing product expansion.
The investment thesis centers on DexCom's leadership in the growing CGM market, supported by strong financial execution and analyst optimism. Key risks include competition from Abbott, the commercial unproven nature of expansion into non-insulin Type 2 diabetes patients, and potential disruption from GLP-1 drug adoption. The consensus price target of $84.33 suggests ~14% upside from current levels.
Plug Power trades at $2.27, up 4.61% today but remains in a bearish technical trend with negative profitability metrics. The company reported a net loss of $1.63 billion on $710 million revenue in 2025, though recent quarterly earnings showed mixed results with a Q1 2026 miss. News highlights include a 50MW electrolyzer order in Australia and asset sales aimed at boosting liquidity, while analyst consensus is divided with a $2.92 price target.
The outlook hinges on Plug Power's path to projected 2028 profitability amid persistent cash burn and high short interest. Investment opportunity exists in hydrogen ecosystem growth, but risks include sustained losses, competitive pressure, and execution challenges in scaling operations globally.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →
